{'fraction_non_alphanumeric': 0.02972972972972973, 'fraction_numerical': 0.005405405405405406, 'mean_word_length': 5.861111111111111, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Gut dysbiosis and gut‐derived inflammation contribute to endothelial dysfunction in Alzheimer’s disease: An in‐vivo cross‐sectional study

Although recent data support an association between certain bacterial strains and Alzheimer’s Disease (AD), it is not clear how these alterations contribute to different aspects of the disease. Increasing evidences also from our group (Cattaneo, AAIC 2020), suggest that endothelial dysfunction, reflected by the upregulation of cell adhesion molecules (CAMs), might have a role in AD pathology development and might be affected by inflammatory mediators. This study aimed at evaluating the gut microbiota (GMB) profile and its association with CAMs and local and systemic inflammation in AD patients.